Corrigendum to: MSTO 1 is a cytoplasmic pro-mitochondrial fusion protein (EMBO Molecular Medicine, (2017), 9, 7, (967-984), 10.15252/emmm.201607058)

Aniko Gal; Peter Balicza; David Weaver; Shamim Naghdi; Suresh K. Joseph; Péter Várnai; Tibor Gyuris; Attila Horváth; Laszlo Nagy; Erin L. Seifert; Maria Judit Molnar; György Hajnóczky

doi:10.15252/emmm.202317911

Corrigendum to: MSTO 1 is a cytoplasmic pro-mitochondrial fusion protein (EMBO Molecular Medicine, (2017), 9, 7, (967-984), 10.15252/emmm.201607058)

Aniko Gal
, Peter Balicza
, David Weaver
, Shamim Naghdi
, Suresh K. Joseph
, Péter Várnai
, Tibor Gyuris
, Attila Horváth
, Laszlo Nagy
, Erin L. Seifert
, Maria Judit Molnar
, György Hajnóczky

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Figure 1C and D, and Table EV1 are retracted along with their corresponding legend. The associated claims regarding the presence of MSTO1 mutation c.22 G > A (p.Val8Met) in the investigated patients and the direct link between this mutation and patients’ myopathy and ataxia phenotypes are retracted. “MSTO P1” and “MSTO P2” are changed into “P1” and “P2,” respectively, throughout the manuscript.

Original language	English (US)
Article number	e17911
Journal	EMBO Molecular Medicine
Volume	15
Issue number	8
DOIs	https://doi.org/10.15252/emmm.202317911
State	Published - Aug 7 2023

ASJC Scopus subject areas

Molecular Medicine

Access to Document

10.15252/emmm.202317911

Cite this

Gal, A., Balicza, P., Weaver, D., Naghdi, S., Joseph, S. K., Várnai, P., Gyuris, T., Horváth, A., Nagy, L., Seifert, E. L., Molnar, M. J., & Hajnóczky, G. (2023). Corrigendum to: MSTO 1 is a cytoplasmic pro-mitochondrial fusion protein (EMBO Molecular Medicine, (2017), 9, 7, (967-984), 10.15252/emmm.201607058). EMBO Molecular Medicine, 15(8), Article e17911. https://doi.org/10.15252/emmm.202317911

Gal, A, Balicza, P, Weaver, D, Naghdi, S, Joseph, SK, Várnai, P, Gyuris, T, Horváth, A, Nagy, L, Seifert, EL, Molnar, MJ & Hajnóczky, G 2023, 'Corrigendum to: MSTO 1 is a cytoplasmic pro-mitochondrial fusion protein (EMBO Molecular Medicine, (2017), 9, 7, (967-984), 10.15252/emmm.201607058)', EMBO Molecular Medicine, vol. 15, no. 8, e17911. https://doi.org/10.15252/emmm.202317911

@article{91f6275f212a4163b4098aff0aa2a8b4,

title = "Corrigendum to: MSTO 1 is a cytoplasmic pro-mitochondrial fusion protein (EMBO Molecular Medicine, (2017), 9, 7, (967-984), 10.15252/emmm.201607058)",

abstract = "Figure 1C and D, and Table EV1 are retracted along with their corresponding legend. The associated claims regarding the presence of MSTO1 mutation c.22 G > A (p.Val8Met) in the investigated patients and the direct link between this mutation and patients{\textquoteright} myopathy and ataxia phenotypes are retracted. “MSTO P1” and “MSTO P2” are changed into “P1” and “P2,” respectively, throughout the manuscript.",

author = "Aniko Gal and Peter Balicza and David Weaver and Shamim Naghdi and Joseph, \{Suresh K.\} and P{\'e}ter V{\'a}rnai and Tibor Gyuris and Attila Horv{\'a}th and Laszlo Nagy and Seifert, \{Erin L.\} and Molnar, \{Maria Judit\} and Gy{\"o}rgy Hajn{\'o}czky",

note = "Publisher Copyright: {\textcopyright} 2023 The Authors.",

year = "2023",

month = aug,

day = "7",

doi = "10.15252/emmm.202317911",

language = "English (US)",

volume = "15",

journal = "EMBO Molecular Medicine",

issn = "1757-4676",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "8",

}

TY - JOUR

T1 - Corrigendum to

T2 - MSTO 1 is a cytoplasmic pro-mitochondrial fusion protein (EMBO Molecular Medicine, (2017), 9, 7, (967-984), 10.15252/emmm.201607058)

AU - Gal, Aniko

AU - Balicza, Peter

AU - Weaver, David

AU - Naghdi, Shamim

AU - Joseph, Suresh K.

AU - Várnai, Péter

AU - Gyuris, Tibor

AU - Horváth, Attila

AU - Nagy, Laszlo

AU - Seifert, Erin L.

AU - Molnar, Maria Judit

AU - Hajnóczky, György

PY - 2023/8/7

Y1 - 2023/8/7

N2 - Figure 1C and D, and Table EV1 are retracted along with their corresponding legend. The associated claims regarding the presence of MSTO1 mutation c.22 G > A (p.Val8Met) in the investigated patients and the direct link between this mutation and patients’ myopathy and ataxia phenotypes are retracted. “MSTO P1” and “MSTO P2” are changed into “P1” and “P2,” respectively, throughout the manuscript.

AB - Figure 1C and D, and Table EV1 are retracted along with their corresponding legend. The associated claims regarding the presence of MSTO1 mutation c.22 G > A (p.Val8Met) in the investigated patients and the direct link between this mutation and patients’ myopathy and ataxia phenotypes are retracted. “MSTO P1” and “MSTO P2” are changed into “P1” and “P2,” respectively, throughout the manuscript.

UR - https://www.scopus.com/pages/publications/85164522407

UR - https://www.scopus.com/pages/publications/85164522407#tab=citedBy

U2 - 10.15252/emmm.202317911

DO - 10.15252/emmm.202317911

M3 - Comment/debate

C2 - 37431817

AN - SCOPUS:85164522407

SN - 1757-4676

VL - 15

JO - EMBO Molecular Medicine

JF - EMBO Molecular Medicine

IS - 8

M1 - e17911

ER -

Corrigendum to: MSTO 1 is a cytoplasmic pro-mitochondrial fusion protein (EMBO Molecular Medicine, (2017), 9, 7, (967-984), 10.15252/emmm.201607058)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this